MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. The company engineered advanced high-density microelectrode arrays (HD-MEAs) as the core of easy-to-use platforms, MaxOne (single-well) and MaxTwo (multi-well), that equip scientists to record electrical signals of neurons in in-vitro 2D and 3D models. MaxWell Biosystems’ HD-MEA technology allows to capture neuronal activity across multiple scales, from sub-cellular to single cells, up to full networks in unprecedented detail. Ultimately, MaxWell Biosystems’ platforms facilitate the understanding of neurological diseases, enhance the efficiency of cell-based assays for toxicity and safety pharmacology, and accelerate drug discovery.